11 | MD Anderson Cancer Center

November 23, 2020

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks...

November 18, 2020

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced a multi-year strategic collaboration...

November 11, 2020

ABSTRACTS 277, 368, 420

Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight...

November 05, 2020

Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of...

Newsroom